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Abstract
A structure-based approach is described for predicting the effects of amino acid substitutions on
protein function. Structures were predicted using a homology modelling method. Folding and
binding energy differences between wild-type and mutant structures were computed to
quantitatively assess the effects of amino acid substitutions on protein stability and protein–protein
interaction, respectively. We demonstrated that pathogenic mutations at the interaction interface
could affect binding energy and destabilise protein complex, whereas mutations at the noninterface might reduce folding energy and destabilise monomer structure. The results suggest that
the structure-based analysis can provide useful information for understanding the molecular
mechanisms of diseases.
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1 Introduction
Revealing the effects of amino acid substitutions on protein structure and function is critical
for understanding the complex mechanisms of human disease caused by single amino acid
mutations. There are 67,000 – 200,000 non-synonymous Single Nucleotide Polymorphisms
(nsSNPs) in the human population (Cargill et al., 1999), which give rise to a large number of
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amino acid substitutions in proteins. The residue changes at key sites within a protein may
result in a series of conformation changes, including the breakage of salt bridges, alteration
of interaction network, disruption of hydrogen bonds, which in turn may perturb the energy
landscape. These changes can affect the kinetics of protein folding or cause protein
aggregation and destabilisation (Dill et al., 1993). More than half of monogenic diseases are
caused by single mutations, and a common mechanism by which amino acid substitutions
cause human disease is protein stability change. Yue and Moult investigated the effect of
amino acid substitutions on protein stability, and estimated that approximately 25% of
nsSNPs in the human population might be deleterious to protein function (Yue and Moult,
2006). Of the known disease-causing missense mutations, the majority (83%) resulted in
alternation of protein stability (Wang and Moult, 2001).
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Amino acid substitutions can also affect protein-protein interactions. Approximately 88% of
disease-associated nsSNPs are found to be located in the voids/pockets important for
protein-protein interactions (Stitziel et al., 2003). The amino acid substitutions located at the
binding interface or active site cleft could block the entrance to the active site, change the
recognition, alter the specificity, or affect the binding affinity. For example, the substitution
G2019S in leucine-rich repeat kinase 2 (LRRK2) was shown to be associated with familial
and sporadic Parkinson’s disease (Aasly et al., 2005). Structure analysis indicates that this
mutation is located at the interface of LRRK2’s N-terminal and C-terminal domains which is
important for positioning of Mg2+ within the active site of the kinase (Albrecht, 2005, Mata
et al., 2006). This finding is in agreement with the experimental result that G2019S enhances
kinase activity in vitro (Kachergus et al., 2005). Recently, Teng et al. (Teng et al., 2009)
examined the effects of nsSNPs at the interaction interfaces of 264 protein complexes using
a homology modeling method and all atoms energy calculations. The results suggest that
disease-causing mutations tend to destabilise protein-protein interactions. Therefore,
understanding how amino acid substitutions affect protein stability and protein-protein
interactions can provide new insights into the molecular mechanisms of human genetic
diseases.
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Protein structure modeling methods have been widely used for predicting the effects of
disease-causing mutations on protein stability and protein-protein interaction. For instance,
to predict the effects of the mutations related to the genetic disorder galactosemia, more than
one hundred mutant structures of galactose-1-phosphate uridyltransferase were constructed
using the homology modeling method, and the results suggested that most mutations might
alter protein stability (Facchiano and Marabotti, 2009). By mapping disease-causing
mutations onto known three-dimensional protein structures, Dimmic and coworkers
(Dimmic et al., 2005) have shown that about 70% of the deleterious mutations are located in
the structurally and/or functionally important sites. However, the effects of mutations were
analyzed statically in these studies. The free energy perturbation (FEP) calculation has been
used to quantitatively assess the effects of amino acid substitutions on protein stability. Dixit
et al. (Dixit et al., 2009) used the AMBER force field and solvent-accessible surface area
solvation methods to calculate the protein stability changes in terms of free energy
differences caused by cancer-associated mutations in the RET and MET kinases, and
showed that the amino acid substitutions could decrease the thermodynamical stability of the
mutant structures. The FEP calculation was also used to assess the protein stability changes
upon single amino acid substitutions in membrane proteins (Park and Lee, 2005).
Nevertheless, these studies on FEP calculation did not take into account the effects of amino
acid substitutions on protein-protein interactions.
The advent of high-throughput sequencing technology makes it possible to identify a large
number of nsSNPs in the human genome. The dbSNP database, one of the primary data
resources for genetic studies, contains the information of more than 23 million human SNPs
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(Smigielski et al., 2000). The records in the dbSNP database are linked to the Online
Mendelian Inheritance in Man (OMIM) database, which contains disease gene information,
including genetic polymorphisms, map locations, inheritance patterns and clinical
descriptions (Wheeler et al., 2007). Computational analyses provide an efficient way for
examining the effects of nsSNPs on protein stability and function, and for identifying
potential disease-causing mutations. Ng and Henikoff (Ng and Henikoff, 2003) used a
position-specific scoring matrix (PSSM) based method called Sorting Intolerant From
Tolerant (SIFT) to predict whether an amino acid substitution affects protein function. We
have recently developed the MuStab web server for predicting protein stability changes
upon amino acid substitutions from sequence features (Teng et al., 2010). MuStab uses a
support vector machine (SVM) model to discriminate between destabilizing and stabilizing
amino acid substitutions in proteins. iPTREE-STAB (Huang et al., 2007) and I-Mutant 3.0
sequence version (Capriotti et al., 2008) are also available for sequence-based prediction of
protein stability changes caused by point mutations. Structure-based methods, including
PoPMuSiC-2.0 (Dehouck et al., 2009), Dmutant (Zhou and Zhou, 2002), Eris (Yin et al.,
2007), I-Mutant 3.0 structure version (Capriotti et al., 2008) and FoldX (Schymkowitz et al.,
2005), are available for examining the effects of mutations on protein stability and proteinprotein interactions. In particular, the FoldX software tool can be used to provide
quantitative estimations about the effects of amino acid substitutions on the stability of
proteins or protein complexes using the empirical force field calculation (Schymkowitz et
al., 2005). Among these protein stability predictors, I-Mutant3.0 structure version, Dmutant
and FoldX gave the best predictive performances (Khan and Vihinen, 2010).
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The experimental approach for determining the effects of amino acid substitutions on
protein stability is to obtain the mutant proteins and measure their thermal stability changes
by melting experiments. However, the experimental approach is time-consuming and thus
may not be applied to a large number of amino acid substitutions. In the present study, a
structure-based approach was performed for predicting the effects of amino acid
substitutions on protein stability and protein-protein interaction. The differences of folding
energy and binding energy between the wild-type and mutant structures were calculated to
predict the protein stability and protein-protein interaction changes caused by the mutations.
The predictions were evaluated by using other bioinformatic methods. The results suggest
that the structure-based approach can provide useful information for characterizing diseasecausing mutations in human genetic studies.

2 Methods
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The schematic diagram of the structure-based approach is shown in Figure 1. The
methodology was also investigated in two previous studies (Teng et al., 2008, Zhang et al.,
2010). For a specific gene with mutations, the related sequence and disease information
were extracted from the dbSNP and OMIM databases. If the structure of the target protein
was available in the Protein Data Bank (PDB), no structure modeling was needed.
Otherwise, target structures were constructed using the homology modeling method (Xiang,
2006). The suitable templates were identified in the PDB database using the PSI-BLAST
program (Altschul et al., 1997), and then used to construct the target structures with the
NEST program (Petrey et al., 2003). Energy minimization was performed to obtain the
optimal structure with the TINKER program (Ponder, 1999), and the mutant structure was
constructed using the SCAP program (Xiang and Honig, 2001). The folding energy of the
wild-type or mutant structure was calculated using TINKER to estimate the effects of the
mutations on protein stability. For amino acid substitutions located at the interface, the
binding energy changes were also computed to predict the effects of the mutations on
protein-protein interaction. At the end, the predictions were compared with several
bioinformatics tools, including FoldX (Schymkowitz et al., 2005), PoPMuSiC-2.0 (Dehouck
Int J Comput Biol Drug Des. Author manuscript; available in PMC 2012 April 4.
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et al., 2009), Dmutant (Zhou and Zhou, 2002), Eris (Yin et al., 2007), MuStab (Teng et al.,
2010), iPTREE-STAB (Huang et al., 2007) and I-Mutant 3.0 (both sequence and structure
versions) (Capriotti et al., 2008).
2.1 Protein structure modeling
Homology modeling was applied to the proteins with no structures available in the PDB
database. The structures were modeled as follows:
1) Template searching—The suitable templates were selected from the PDB database for
the target protein. Position-Specific Iterated BLAST (PSI-BLAST) (Altschul et al., 1997)
was used for the template searching. The structures with significant E-value (< 10−5) were
selected as the suitable templates.
2) Structure building—The program NEST was used to the build structure models
according to the sequence alignment between the target protein and its structural template
(Petrey et al., 2003). NEST is an integrated model-building program, including the program
LOOPY9 for loop prediction and SCAP10 for side-chain modeling.
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3) Energy minimization—To generate the optimal structure, energy minimization was
performed by using the TINKER package (Ponder, 1999) with the CHARMM27 force field
parameters (Brooks et al., 1983). The MINIMIZE program in TINKER was used to
minimize structures with the algorithm of Limited Memory BFGS Quasi-Newton
Optimization (Ponder, 1999).
The mutant structures were derived in silico from the wild-type structure using the SCAP
program (Xiang and Honig, 2001). The amino acid substitutions were introduced by sidechain replacements with the rest of the structure kept rigid. The MINIMIZE program in the
TINKER package was used to minimize the mutant structures.
2.2 Folding energy calculation
The effects of amino acid substitutions on protein stability were assessed by the folding
energy changes. The energy calculation was based on the monomer structure of the target
protein, and was performed as described in the recent publication (Zhang et al., 2010). The
folding energy is the energy difference between the folded and unfolded states:
(1)
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where G(folded) or G(unfolded) is the total potential energy of the target protein in the
folded or unfolded state, respectively.
The protein stability change (ΔΔGstability) is the folding energy difference between the wildtype (WT) structure and the structure with the amino acid substitution (AAS). It can be
calculated using the following equation:
(2)

However, the energy difference between the wild-type and mutant proteins in the unfolded
state, G(unfolded: WT) - G(unfolded: AAS), is difficult to calculate. In the present study, we
assume that the difference of energy in the unfolded state can be estimated by using the
substitution site and its neighboring residues. The total potential energy of the elevenresidue segment (S11) with the substitution site in the middle position was used to represent
Int J Comput Biol Drug Des. Author manuscript; available in PMC 2012 April 4.
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the folding energy of the full-length protein in the unfolded state. Equation (2) can thus be
rewritten as:
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(3)

All of the above total potential energy terms were calculated using the ANALYZE program
in the TINKER package. A positive value of ΔΔGstability indicates that the amino acid
substitution may make the protein more stable, whereas a negative value of ΔΔGstability
suggests that the mutation can destabilise the protein.
2.3 Binding energy calculation
For an amino acid substitution located at the interaction interface, the binding energy
difference of the protein complex between the wild-type and mutant structures was used to
assess the effect of the mutation on protein-protein interaction. As described in the previous
study (Teng et al., 2009), the binding energy was calculated using the rigid body approach,
in which the structures of the monomers were kept as they were in the dimer complex. The
binding energy, ΔΔG(binding), was the difference between the total potential energy of the
dimer complex and the individual monomers:

NIH-PA Author Manuscript

(4)

where ΔG(folding: complex), ΔG(folding: A) and ΔG(folding: B) are the folding free energy
values of the dimer complex, monomer A and monomer B, respectively. Since the internal
mechanical energy values of the unbound and bound monomers are the same, the energy
terms in the unfolded state can be canceled out in equation (4). Thus, the binding free energy
can be calculated as below:
(5)

where G(folded: complex), G(folded) and G(folded) are the total potential energy values of
the dimer complex, monomer A and monomer B in the folded state, respectively.
In this study, the total potential energy was computed using the ANALYZE program in the
TINKER package. The effect of an amino acid substitution on protein-protein interaction
was assessed by using the binding energy difference between the wild-type (WT) structure
and the structure with the amino acid substitution (AAS):
(6)
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A positive value of the binding energy change (ΔΔΔGbinding) indicates that the amino acid
substitution may strengthen the binding affinity and make the protein dimer complex more
stable. In contrast, a negative value of ΔΔΔGbinding suggests that the mutation can weaken
the binding affinity and destabilise the dimer complex.
2.4 Prediction evaluation
Several bioinformatic tools were used to evaluate the predictive power of the structure-based
approach used in this study, and the predictions were considered to be reliable if a consensus
was reached by most of the predictors. Sequence-based prediction of the direction of protein
stability change could give useful information. Three sequence-based tools were used to
predict the directions of protein stability changes caused by amino acid substitutions from
primary sequence data, including iPTREE-STAB (http://210.60.98.19/IPTREEr/iptree.htm),
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MuStab (http://bioinfo.ggc.org/mustab/) and I-Mutant3.0 (sequence version)
(http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi).

NIH-PA Author Manuscript

Structure-based prediction methods could provide quantitative assessment of the effects of
amino acid substitutions on protein stability. Khan and Vihinen (Khan and Vihinen, 2010)
compared the predictive performances of different protein stability predictors, and showed
that three structure-based tools, including I-Mutant3.0 (structure version)
(http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi), Dmutant
(http://sparks.informatics.iupui.edu/hzhou/mutation.html) and FoldX (Schymkowitz et al.,
2005) were the most reliable predictors. These three tools were used in this study. Other two
structure-based predictors, including PoPMuSiC-2.0 (http://babylone.ulb.ac.be/popmusic/)
and Eris (http://eris.dokhlab.org), were also used to calculate the folding energy for
monomer structures, respectively. The difference of the folding energy between the wildtype and mutant structures was used to assess the protein stability change caused by an
amino acid substitution, and compared with the ΔΔGstability value calculated using the
approach applied in this paper. Furthermore, FoldX was also used to determine the
interaction energy of complex protein. The effect of an amino acid substitution on proteinprotein interaction was estimated by the interaction energy difference of the protein complex
between the wild-type and mutant structures (ΔΔΔGFoldX), which was compared with
ΔΔΔGbinding computed using the method utilized in this study.
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In addition, ClustalX (Larkin et al., 2007) was used to perform the multiple sequence
alignment for conservation analysis. Protein sequences from different species were
downloaded from the NCBI Entrez database using the GENE search option with the gene
name as the query.

3 Results and discussion
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To evaluate the usefulness of the structure-based approach utilized in this paper, three case
studies were carried out for four pathogenic mutations and one neutral nsSNP in three
human genes (Table 1). One disease-causing mutation, A111V (dbSNP ID: rs28928889,
OMIM ID: 141850.0029), and one neutral nsSNP, T119N (dbSNP ID: rs1058069), in the
human HBA2 gene (haemoglobin subunit alpha) were used to show their different effects on
protein stability and protein-protein interaction. Two pathogenic mutations, Q61K (dbSNP
ID: rs28933406, OMIM ID: 190020.0002) and A146T (dbSNP ID: rs104894231, OMIM
ID: 190020.0008), in the human HRAS gene (v-Ha-ras Harvey rat sarcoma viral oncogene
homolog) were analyzed to assess the effects of mutations on different structural regions
(interface or non-interface). The computational approach was also used to investigate the
substitution, A693V, in the human ZBTB20 gene (zinc finger and BTB domain containing
20). As discussed in the following sections, the results suggest that the pathogenic mutations
make the monomer structures less stable (ΔΔGstability < 0), and/or weaken the binding
affinity to destabilise the dimer structures (ΔΔΔGbinding < 0). In contrast, the neutral nsSNP
has only slight effects on protein stability and protein-protein interaction (ΔΔGstability and
ΔΔΔGbinding close to 0).
It was shown that the predictions agree well with the results gave by the most of structurebased methods. However, the sequence-based tools often did not agree with the consensus
predictions from the structure-based methods (Table 1). The structure-based predictors (IMutant3.0 structure version, Dmutant and FoldX) appeared to be more reliable for
predicting protein stability changes caused by mutations (Khan and Vihinen, 2010). Thus,
this study focused on the structure-based analyses.
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Haemoglobin molecules in red blood cells transport oxygen from the lung to the peripheral
tissues, and thus are important for maintaining cell viability. Human haemoglobin is made
up of symmetric dimers of polypeptide chains, the α/β-globin dimers (Kan, 1991). Several
point mutations in α-globin have been shown to cause α-thalassemia, which can result in
Hydrops fetalis (Chui and Waye, 1998). In this study, the two amino acid substitutions of
human haemoglobin subunit alpha (HBA2), A111V and T119N, were analyzed to show the
different effects of disease-causing and neutral amino acid substitutions on protein stability
and protein-protein interaction. The homodimer structure of HBA2 was built using the
crystal structure of human deoxy haemoglobin (PDB: 1O1P) as the template.
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The majority of disease-causing mutations cause protein destabilisation, whereas most
neutral nsSNPs have limited effect on protein stability (Wang and Moult, 2001). In the
present study, the predicted effects of A111V (disease-causing) and T119N (neutral) on
protein stability agree well with the previous observations. As shown in Table 1, the folding
energy change (ΔΔGstability) caused by A111V is −0.75 kcal/mol, suggesting that the
mutation may destabilise haemoglobin monomer structure. The decreased protein stability is
also predicted for the A111V mutation by three structure-based tools including FoldX,
PoPMuSiC-2.0 and Dmutant (Table 1). In contrast, the neutral nsSNP (T119N) is predicted
by our calculations and three structure-based tools (FoldX, Dmutant and Eris) to stabilize
the protein monomer. PoPMuSiC-2.0 and I-Mutant3.0 (structure version) give the opposite
predictions. The results suggest that T119N may not cause destabilisation of the monomer
structure.
Amino acid substitutions at the interaction interface may result in binding affinity changes,
and thus affect the structure of the protein complex. As shown in Figure 2a, the pathogenic
mutation, A111V, is located in the α-helix of the HBA2 binding interface. Although most
regions of the wild-type and mutant structures are similar, the structures are not overlapped
in the α-helix interface region. This structural change may significantly affect the binding
energy, and make the protein complex unstable. The observation has been confirmed by the
binding energy calculation using both TINKER and FoldX (ΔΔΔGbinding = −11.56 kcal/mol
and ΔΔΔGFoldX = −1.41 kcal/mol) (Table 2). In contrast, the neutral nsSNP (T119N) is
located in the flexible loop region (Figure 2b). Since T119N is not located in the inner
region of the interface, it may not significantly affect protein-protein interaction. The
binding energy change caused by T119N is ΔΔΔGbinding = 0.90 kcal/mol (Table 2), which is
smaller than the absolute value of binding energy change caused by A111V.
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In addition, the multiple sequence alignment shown in Figure 2c suggests that the residue,
Ala 111, is well conserved, but Thr 119 is not conserved in Xenopus laevis and Xenopus
tropicalis. The result agrees with the previous observation that pathogenic mutations tend to
be located at evolutionarily conserved positions (Miller and Kumar, 2001).
3.2 Pathogenic mutations at the interface or non-interface of HRAS
Follicular carcinoma is the second most common thyroid cancer, which accounts for about
15% of all thyroid malignancies. The v-Ha-ras Harvey rat sarcoma viral oncogene homolog
(HRAS) encodes a follicular cancer-related protein located at the inner surface of cell
membrane. The protein plays an important role in the transduction of signals arising from
tyrosine kinase and G protein-coupled receptors. One pathogenic mutation (Q61K) in HRAS
was found to cause constitutive activation of the downstream signaling pathways
(Nikiforova et al., 2003). Another disease-causing mutation (A146T) was identified in
patients with Costello syndrome, and was shown to affect the GTP/GDP binding of HRAS
(Zampino et al., 2007). In this study, the heterodimer structure of HRAS has been built using
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the crystal structure of the transforming protein RhoA (PDB: 1OW3) as the template. The
amino acid substitution Q61K is located at the interaction interface (Figure 3a), and A146T
lies in a non-interface region of HRAS (Figure 3b). These two mutations in different
structural regions have been analyzed to assess their effects on protein stability and proteinprotein interaction.
Both amino acid residues in the HRAS protein, Gln 61 and Ala 146, are conserved in other
species (Figure 3c), suggesting that they may be functionally important sites. As shown in
Table 1, the folding energy changes (ΔΔGstability) caused by Q61K and A146T are −4.42
kcal/mol and −1.39 kcal/mol (Table 1), respectively, suggesting that both mutations may
destabilise the HRAS monomer structure. Consistent with the above results, the predictions
made by structure-based tools show decreased protein stability for both mutations
(excluding I-Mutant3.0 structure version for Q61K). Furthermore, all the sequence-based
methods also predict that A146T could make HRAS protein unstable.
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The Q61K mutation is located at the interaction interface (Figure 3a), and the binding
energy change caused by Q61K is ΔΔΔGbinding = −7.29 kcal/mol, or ΔΔΔGFoldX = −2.40
kcal/mol (Table 1), suggesting that the mutation may significantly affect protein-protein
interaction. The distance between Gln 61 and its interaction partner, Arg 47 from the other
chain, is only 1.88 A, which is within the distance of hydrogen bond formation. When the
polar residue Gln is replaced by positively charged residue Lys, the hydrogen bonds may be
affected, and thus make strongly unfavorable interactions with Arg 47. In contrast, the
A146T mutation located in a non-interface region (Figure 3b) does not appear to have a
significant effect on protein-protein interaction. As shown in Table 1, the binding energy
change caused by A146T is ΔΔΔGbinding = −0.21 kcal/mol, or ΔΔΔGFoldX = −0.11 kcal/mol.
Nevertheless, Ala 146 and its neighboring residues (Leu 15 and Val 148) may form the
hydrophobic pocket, which is involved in the binding of the purine ring of GTP/GDP. The
substitution of Ala 146 by the polar residue Thr may alter the hydrophobic environment in
the pocket, and thus affect the binding of GTP or GDP.
3.3 Application: the A693V substitution in ZBTB20
The structure-based approach was also used to investigate the amino acid substitution,
A693V, in the human ZBTB20 gene (zinc finger and BTB domain containing 20). ZBTB20
plays important roles in neurogenesis (Mitchelmore et al., 2002), postnatal survival and
glucose homeostasis (Sutherland et al., 2009). The A693V substitution is implicated to
impair the function of ZBTB20 in the brain. Thus, predicting the effects of A693V on
protein stability and function may help determine the pathogenic potential of the amino acid
substitution.
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The structure of the C-terminal region (560-739) of ZBTB20, including five zinc finger
domains, was constructed using the homology modeling method with the six-finger zinc
finger peptide (PDB: 2I13) as the template. As shown in Figure 4a, although ZBTB20 may
form a homodimer structure, the A693V mutation is not located at the interaction interface.
The binding energy change caused by A693V is ΔΔΔGbinding = −0.31 kcal/mol, or
ΔΔΔGFoldX = 0 kcal/mol (Table 2), suggesting that the amino acid substitution has little
effect on dimer formation. The folding energy change was also calculated for A693V using
TINKER (ΔΔGstability = −2.69 kcal/mol, Table 1). In addition, all of the structure-based
methods predicted that A693V will decrease protein stability. Thus, the consensus prediction
is that A693V will slightly destabilise the monomer structure of ZBTB20.
Since the ZBTB20 protein was previously shown to bind DNA (Mitchelmore et al., 2002),
the structure of ZBTB20 in complex with DNA has been modeled using the six-finger zinc
finger peptide (PDB: 2I13) as the template. As shown in Figure 4b, the amino acid residue,
Int J Comput Biol Drug Des. Author manuscript; available in PMC 2012 April 4.
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Ala 693, is located close to the phosphate group of DNA backbone. Therefore, another
possibility is that the A693V substitution may be involved in protein-DNA interaction. The
multiple sequence alignment shown in Figure 4c also suggests that Ala 693 is highly
conserved in other species, and thus may be important for the normal function of ZBTB20.

4 Conclusion
In this paper, a structure-based approach is described for assessing the effects of amino acid
substitutions on protein stability and protein-protein interaction. Homology modeling and
free energy calculation methods were used to compute the differences of folding energy and
binding energy between the wild-type and mutant structures. Three case studies showed that
the disease-causing mutations at the interaction interface might reduce the binding energy,
and thus weaken the affinity in the protein complex. The pathogenic mutations in the noninterface region could reduce the folding energy and thus destabilise the monomer structure.
Therefore, the structure-based approach can be used to quantitatively assess the effects of
amino acid substitutions on protein stability and protein-protein interaction. The approach
may be useful for understanding the molecular mechanisms by which gene mutations cause
human diseases.
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Figure 1.
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Schematic diagram of the approach for assessing the effects of amino acid substitutions on
protein stability and protein-protein interaction. Underlined are the software tools used in
this study.
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Figure 2. Illustration of two amino acid substitutions (A111V and T119N) in human HBA2

a) Structural representation of the A111V mutation. The wild-type chain A is shown in
green color, mutant chain A in cyan, wild-type chain B in yellow, and mutant chain B in
orange. The amino acid residue Ala 110 (wild-type) is shown in magenta, and Val 110
(mutant) in white.
b) Structural representation of T119N. Chains A and B are shown in green and yellow,
respectively. The residue Asn 119 (wild-type) is shown in pink, and Thr 119 (mutant) in
blue.
c) Multiple sequence alignment of HBA2 with the amino acid substitution sites indicated.
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Figure 3. Illustration of two disease-causing mutations (Q61K and A146T) in human HRAS

a) Structural representation of the Q61K mutation. Chains A and B are shown in green and
yellow, respectively. The residue Gln 61 (wild-type) is shown in red, Lys 61 (mutant) in
blue, and Arg 47 of chain B in cyan. The hydrogen bond is represented as a white dash line.
b) Structural representation of the A146T mutation. Chains A and B are shown in green and
yellow, respectively. Ala 146 (wild-type) is shown in magenta, and Thr 146 (mutant) in
blue. Two neighboring residues, Leu 15 in orange and Val 148 in white, are also shown.
c) Multiple sequence alignment of HRAS with the amino acid substitution sites indicated.

NIH-PA Author Manuscript
Int J Comput Biol Drug Des. Author manuscript; available in PMC 2012 April 4.

Teng et al.

Page 18

NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 4. Illustration of the A693V mutation in human ZBTB20

a) Structural representation of the A693V mutation. Chains A and B are shown in green and
yellow, respectively. Ala 693 (wild-type) is shown in magenta, and Val 693 (mutant) in
white.
b) Representation of the modeled structure of ZBTB20 in complex with DNA. Shown are
chain A in green, Ala 693 in magenta, Val 693 in white, and the DNA molecule as
wireframe.
c) Multiple sequence alignment of ZBTB20 with the amino acid substitution site indicated.
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Sequence-based Tools

Structure-based Tools

Amino acid substitution
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Increased
Increased
Increased

MuStab
iPTREE-STAB
Consensus
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I-Mutant 3.0 (sequence version)

Consensus
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Decreased
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Increased
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Increased

Increased

Increased

Decreased

Decreased
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Decreased

−0.79
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0.13

I-Mutant 3.0 (structure version)

−0.30

4.28

Eris

−0.38

−1.24

0.32

−0.48

Dmutant

−0.24

−0.22

−0.24

−0.50

−0.49

PoPMuSiC-2.0

−2.74

−1.39

−2.63

10.54

−4.19

FoldX

−4.42

A146T (HRAS)

−0.38

0.06

−0.75

ΔΔGstability

Q61K (HRAS)

2.29

T119N (HBA2)

A111V (HBA2)

The effects of five amino acid substitutions on protein stability. The unit of energy change is kcal/mol.

Increased

Decreased

Increased

Increased

Decreased

−0.03

−0.72

−0.34

−0.05

−0.68

−2.69

A693V (ZBTB20)
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T119N (HBA2)
0.90
1.39

A111V (HBA2)
−11.56
−1.41

ΔΔΔGbinding

ΔΔΔGFoldX

Amino acid substitution

−2.40

−7.29

Q61K (HRAS)

−0.11

−0.21

A146T (HRAS)

0.00

−0.31

A693V (ZBTB20)

The effects of five amino acid substitutions on protein-protein interaction. The unit of energy change is kcal/mol.
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